FR3079142B1 - Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables - Google Patents

Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables Download PDF

Info

Publication number
FR3079142B1
FR3079142B1 FR1852515A FR1852515A FR3079142B1 FR 3079142 B1 FR3079142 B1 FR 3079142B1 FR 1852515 A FR1852515 A FR 1852515A FR 1852515 A FR1852515 A FR 1852515A FR 3079142 B1 FR3079142 B1 FR 3079142B1
Authority
FR
France
Prior art keywords
bioassimilable
peptides
superoxide dismutase
composition containing
veterinary composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1852515A
Other languages
English (en)
Other versions
FR3079142A1 (fr
Inventor
Cecile Destaing
Pascal Renaglia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mp Labo Fr
Original Assignee
Matieres Premieres Internationales
Matieres Premieres Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matieres Premieres Internationales, Matieres Premieres Int filed Critical Matieres Premieres Internationales
Priority to FR1852515A priority Critical patent/FR3079142B1/fr
Priority to CN201980021322.5A priority patent/CN112236160A/zh
Priority to US17/040,209 priority patent/US20210008174A1/en
Priority to EP19718786.7A priority patent/EP3768292A1/fr
Priority to PCT/FR2019/050650 priority patent/WO2019180388A1/fr
Priority to MA052141A priority patent/MA52141A/fr
Publication of FR3079142A1 publication Critical patent/FR3079142A1/fr
Application granted granted Critical
Publication of FR3079142B1 publication Critical patent/FR3079142B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/22—Animal feeding-stuffs from material of animal origin from fish
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001—Superoxide dismutase (1.15.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

Composition vétérinaire comprenant, en quantités efficaces, de la superoxyde dismutase et au moins un hydrolysat de protéines riche en peptides bioassimilables.
FR1852515A 2018-03-23 2018-03-23 Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables Active FR3079142B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1852515A FR3079142B1 (fr) 2018-03-23 2018-03-23 Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables
CN201980021322.5A CN112236160A (zh) 2018-03-23 2019-03-21 包含超氧化物歧化酶和至少一种富含生物可同化肽的蛋白水解物的兽用组合物
US17/040,209 US20210008174A1 (en) 2018-03-23 2019-03-21 Veterinary Composition Comprising Superoxide Dismutase and at Least One Hydrolysate of Proteins Rich in Bioassimilable Peptides
EP19718786.7A EP3768292A1 (fr) 2018-03-23 2019-03-21 Composition vétérinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de protéines riche en peptides bioassimilables
PCT/FR2019/050650 WO2019180388A1 (fr) 2018-03-23 2019-03-21 Composition vétérinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de protéines riche en peptides bioassimilables
MA052141A MA52141A (fr) 2018-03-23 2019-03-21 Composition vétérinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de protéines riche en peptides bioassimilables

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1852515 2018-03-23
FR1852515A FR3079142B1 (fr) 2018-03-23 2018-03-23 Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables

Publications (2)

Publication Number Publication Date
FR3079142A1 FR3079142A1 (fr) 2019-09-27
FR3079142B1 true FR3079142B1 (fr) 2020-11-27

Family

ID=63080011

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1852515A Active FR3079142B1 (fr) 2018-03-23 2018-03-23 Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables

Country Status (6)

Country Link
US (1) US20210008174A1 (fr)
EP (1) EP3768292A1 (fr)
CN (1) CN112236160A (fr)
FR (1) FR3079142B1 (fr)
MA (1) MA52141A (fr)
WO (1) WO2019180388A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020250626A1 (en) * 2019-04-05 2021-10-07 Novozymes A/S Redox enzymes in animal feed compositions
CN116390651A (zh) * 2020-10-15 2023-07-04 帝斯曼知识产权资产管理有限公司 调节胃肠道代谢物的方法
CN112931701B (zh) * 2021-03-09 2022-01-07 清远希普生物科技有限公司 一种含有酶解鱼肽粉的营养组合物及其制备方法与应用
US20220112423A1 (en) * 2021-12-22 2022-04-14 Bomi Patel-Framroze Novel Protein Hydrolysate Composition that Increases Coalbed Methane Production
FR3141617A1 (fr) * 2022-11-08 2024-05-10 Laboratoire Dielen Composition pour son utilisation dans le traitement d’un syndrome de l'intestin irritable et/ou dans le traitement d’une hyperperméabilité intestinale.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716884B1 (fr) 1994-03-03 1996-10-04 Bio Obtention Sc Extrait protéique de cucumis melo à activité antioxydante et procédé de préparation, composition cosmétique ou pharmaceutique ou composition alimentaire contenant un tel extrait.
KR100880537B1 (ko) * 2008-10-07 2009-01-28 (주)씨스팜 칸탈로프 멜론추출물과 글리아딘 결합물을 유효성분으로 하는 기억, 집중력, 학습능력 개선제
AU2012315586B2 (en) * 2011-09-29 2017-07-20 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
FR3003164B1 (fr) 2013-03-13 2015-10-23 Activinside Composition contenant de la superoxyde dismutase issue de vitis vinifera
FR3003165B1 (fr) 2013-03-13 2016-08-19 Activinside Composition contenant de la superoxyde dismutase issue d'olea europeae
EP3046552A1 (fr) * 2013-07-02 2016-07-27 International Nutrition Research Company Composition intervenant dans la regulation du dysfonctionnement des cycles de l'energie, de l'inflammation et de l'insulinoresistance et son utilisation notamment dans les maladies cardiometaboliques
FR3032721B1 (fr) 2015-02-12 2020-03-27 Bionov Melange de sod purifiees d'origine vegetale
FR3036923B1 (fr) * 2015-06-08 2017-05-26 Dielen Lab Hydrolysat de proteines de poissons
CN106901113A (zh) * 2017-03-14 2017-06-30 广东科贸职业学院 Sod饮料及其制备方法

Also Published As

Publication number Publication date
WO2019180388A1 (fr) 2019-09-26
MA52141A (fr) 2021-01-27
EP3768292A1 (fr) 2021-01-27
CN112236160A (zh) 2021-01-15
FR3079142A1 (fr) 2019-09-27
US20210008174A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
FR3079142B1 (fr) Composition veterinaire comprenant de la superoxyde dismutase et au moins un hydrolysat de proteines riche en peptides bioassimilables
BR112017015567A2 (pt) proteína gl de citomegalovírus recombinante ou fragmento de formação de complexo da mesma, complexo de citomegalovírus, ácido nucleico isolado, célula hospedeira, e, composição imunogênica
BR112021020023A2 (pt) Ligantes de conjugação melhorados
GEP20227447B (en) Constructs having sirp-alpha domain or variant thereof
CY1117727T1 (el) Φαρμακευτικες συνθεσεις κλωστηριδιακης τοξινης σταθεροποιημενης χωρις πρωτεϊνη
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
ATE551048T1 (de) Proteinhydrolysate enthaltende kosmetische zusammensetzungen
PE20140673A1 (es) Nuevos moduladores y metodos para su uso
TR201906789T4 (tr) Üretim ve enjeksiyon cihazlarında kullanım için en uygun olan propilen glikol ihtiva eden peptit formülasyonları.
EA200701918A1 (ru) Белок липокалин
PE20081392A1 (es) Moleculas de enlace de lingo
DE502006006364D1 (de) Copolymere auf basis von polyalkylenoxid-modifizierten n-vinyllactam-copolymeren
BR112019002127A2 (pt) proteína de fusão, vetor, célula, composição farmacêutica, e, uso da proteína de fusão
AU2019321490A8 (en) Ox40-binding polypeptides and uses thereof
GEP20207139B (en) Liquid neurotoxin formulation stabilized with tryptophan or tyrosine
WO2019014260A3 (fr) Potentialisation de composant sanguin de l'activité antibactérienne de la protéine lytique et méthodes et utilisations associées
WO2004111081A3 (fr) Peptides antigeniques de coronavirus de sars, et utilisations
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
BR112015021960A2 (pt) Células hospedeiras e métodos de uso
BR112022010179A2 (pt) Anticorpos anti-vírus da febre amarela, e métodos de sua geração e uso
EA202190136A1 (ru) Способ очистки антигена
WO2020005846A8 (fr) Marquage de l'adn
CL2020002459A1 (es) Variantes de anticuerpo c-terminales
MX2023012141A (es) Peptidos inmunogenicos magec2, proteinas de union que reconocen peptidos inmunogenicos magec2, y usos de estos.
MX2023005179A (es) Proteínas de unión que reconocen antígeno ha-1 y usos de las mismas.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190927

PLFP Fee payment

Year of fee payment: 3

CD Change of name or company name

Owner name: MP LABO, FR

Effective date: 20210201

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7